VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,150 | +87453.6% | 9,110 | -2.1% | 0.28% | +26.4% |
| Q2 2023 | $280 | -6.4% | 9,310 | +7.5% | 0.22% | -2.2% |
| Q1 2023 | $299 | +20.6% | 8,657 | 0.0% | 0.22% | +21.0% |
| Q4 2022 | $248 | -99.9% | 8,657 | -3.3% | 0.19% | +8.1% |
| Q3 2022 | $216,000 | -15.3% | 8,957 | -3.8% | 0.17% | -9.0% |
| Q2 2022 | $255,000 | -29.8% | 9,312 | -1.7% | 0.19% | -12.5% |
| Q1 2022 | $363,000 | +21.8% | 9,472 | +1.8% | 0.22% | +33.3% |
| Q4 2021 | $298,000 | +2.1% | 9,307 | -6.1% | 0.16% | -5.3% |
| Q3 2021 | $292,000 | -13.6% | 9,907 | -0.4% | 0.17% | -13.2% |
| Q2 2021 | $338,000 | +3.7% | 9,944 | -0.8% | 0.20% | -5.7% |
| Q1 2021 | $326,000 | -7.1% | 10,020 | +2.8% | 0.21% | -18.0% |
| Q4 2020 | $351,000 | -8.1% | 9,745 | 0.0% | 0.26% | -16.9% |
| Q3 2020 | $382,000 | +7.0% | 9,745 | 0.0% | 0.31% | -5.5% |
| Q2 2020 | $357,000 | – | 9,745 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |